408 related articles for article (PubMed ID: 15189745)
1. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.
Stanaland BE
Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745
[TBL] [Abstract][Full Text] [Related]
2. Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray.
Shah SR; Miller C; Pethick N; Uryniak T; Jones MK; O'Dowd L
Clin Ther; 2003 Aug; 25(8):2198-214. PubMed ID: 14512128
[TBL] [Abstract][Full Text] [Related]
3. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost.
Herman H
Am J Rhinol; 2007; 21(1):70-9. PubMed ID: 17283565
[TBL] [Abstract][Full Text] [Related]
4. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
[TBL] [Abstract][Full Text] [Related]
5. Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray.
Murphy K; Uryniak T; Simpson B; O'Dowd L
Ann Allergy Asthma Immunol; 2006 May; 96(5):723-30. PubMed ID: 16729787
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
[TBL] [Abstract][Full Text] [Related]
7. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.
Fokkens WJ; Cserháti E; dos Santos JM; Praca F; van Zanten M; Schade A; Simon G
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):279-84. PubMed ID: 12269648
[TBL] [Abstract][Full Text] [Related]
8. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis.
Davies RJ; Nelson HS
Clin Ther; 1997; 19(1):27-38; discussion 2-3. PubMed ID: 9083706
[TBL] [Abstract][Full Text] [Related]
9. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide.
Agertoft L; Pedersen S
J Allergy Clin Immunol; 1999 Nov; 104(5):948-52. PubMed ID: 10550737
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis.
Day J; Carrillo T
J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):902-8. PubMed ID: 9847429
[TBL] [Abstract][Full Text] [Related]
11. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?
Yawn B
MedGenMed; 2006 Jan; 8(1):23. PubMed ID: 16915153
[TBL] [Abstract][Full Text] [Related]
12. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
Meltzer EO
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557
[TBL] [Abstract][Full Text] [Related]
13. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis.
Reissman D; Price T; Leibman CW
J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101
[TBL] [Abstract][Full Text] [Related]
14. Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis.
Kivisaari E; Baker RC; Price MJ
Clin Exp Allergy; 2001 Jun; 31(6):855-63. PubMed ID: 11422149
[TBL] [Abstract][Full Text] [Related]
15. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
Meltzer EO; Bardelas J; Goldsobel A; Kaiser H
Treat Respir Med; 2005; 4(4):289-96. PubMed ID: 16086602
[TBL] [Abstract][Full Text] [Related]
16. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
Onrust SV; Lamb HM
Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
[TBL] [Abstract][Full Text] [Related]
17. Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group.
Creticos P; Fireman P; Settipane G; Bernstein D; Casale T; Schwartz H
Allergy Asthma Proc; 1998; 19(5):285-94. PubMed ID: 9801742
[TBL] [Abstract][Full Text] [Related]
18. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.
Wilson AM; Sims EJ; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):598-604. PubMed ID: 9802367
[TBL] [Abstract][Full Text] [Related]
19. A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis.
Stern MA; Dahl R; Nielsen LP; Pedersen B; Schrewelius C
Am J Rhinol; 1997; 11(4):323-30. PubMed ID: 9292184
[TBL] [Abstract][Full Text] [Related]
20. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
Schenkel EJ; Skoner DP; Bronsky EA; Miller SD; Pearlman DS; Rooklin A; Rosen JP; Ruff ME; Vandewalker ML; Wanderer A; Damaraju CV; Nolop KB; Mesarina-Wicki B
Pediatrics; 2000 Feb; 105(2):E22. PubMed ID: 10654982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
